Applied dna to submit application to new york state department of health to expand intended use of linea mpox virus 1.0 assay to mpox clade i

Stony brook, ny / accesswire / august 19, 2024 / applied dna sciences, inc. (nasdaq:apdn) (applied dna), a leader in pcr-based dna technologies, today announced its intention to seek an expansion of the approved intended use of its linea™ mpox virus 1.0 assay (the "assay") to include the detection of mpox clade i that is the subject of the world health organization's (who) 14 august 2024 declaration of a public health emergency of international concern (pheic). the company's internally generated data show that the assay can detect the genetic sequence of mpox clade i and is now undertaking validation studies to enable the filing of necessary documentation with the new york state department of health (nysdoh).
APDN Ratings Summary
APDN Quant Ranking